We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.54%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.02B
AUM Growth
+$145M
(+5%)
Cap. Flow
-$41.1M
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
45.87%
Holding
173
New
19
Increased
36
Reduced
34
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gogo Inc
GOGO
|
+$49.8M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$28.8M |
| 3 |
Fox Factory Holding Corp
FOXF
|
+$27.8M |
| 4 |
SLNO
Soleno Therapeutics
SLNO
|
+$24.7M |
| 5 |
Peloton Interactive
PTON
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Establishment Labs
ESTA
|
+$59.5M |
| 2 |
ABVX
Abivax
ABVX
|
+$44.1M |
| 3 |
Cogent Biosciences
COGT
|
+$35.3M |
| 4 |
Amneal Pharmaceuticals
AMRX
|
+$20.3M |
| 5 |
IMAX
IMAX
|
+$18.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.48% |
| 2 | Consumer Discretionary | 8.75% |
| 3 | Financials | 3.52% |
| 4 | Communication Services | 3.05% |
| 5 | Industrials | 1.45% |
Similar funds
TAM
FNF
CA
XL
NB
MASUI
PA
BCM
Nantahala Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Nantahala Capital Management held 173 positions worth $3.02B, up 5% from $2.88B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Nantahala Capital Management's Q4 2025 filing shows 19 new, 36 increased, 34 reduced and 20 closed positions. Its largest new stake was Gogo Inc: 6,792,649 shares worth $31.7M. The largest sale was Establishment Labs, an estimated $59.5M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nantahala Capital Management's largest Q4 2025 buy was Gogo Inc: 6,792,649 shares worth $31.7M.
- Nantahala Capital Management added most to Fox Factory Holding Corp in Q4 2025, an estimated $27.8M increase.
- Nantahala Capital Management's biggest Q4 2025 reduction was Establishment Labs, cutting an estimated $59.5M.
- Nantahala Capital Management fully exited Palvella Therapeutics in Q4 2025, selling an estimated $15.7M.
- Nantahala Capital Management's ten largest holdings make up 46% of its $3.02B portfolio in Q4 2025.
- Nantahala Capital Management opened 19 new positions and closed 20 in Q4 2025.
- Nantahala Capital Management's portfolio value rose 5% quarter-over-quarter to $3.02B.
Based on Nantahala Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.